These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Clinical observation on Chinese drug acupoint-injection for treatment of acquired abducent paralysis].
    Author: Ren H, Cheng FK, Qiu C.
    Journal: Zhongguo Zhen Jiu; 2008 Jan; 28(1):41-3. PubMed ID: 18257188.
    Abstract:
    OBJECTIVE: To seek for an effective therapy for abducent paralysis. METHODS: Seventy-six cases of abducent paralysis were randomly divided into an acupoint-injection group and a western medicine group. The acupoint-injection group were treated by point-injection therapy, with Jingming (BL 1), Yangbai (GB 14), Sibai (ST 2), Tongziliao (GB 1) on the affected side, and bilateral Ganshu (BL 18) used as basic points and compound Danggui Injection as the principal injected medicine, and in combination with corresponding acupoints and injected medicine according to different syndrome types. The western medicine group were treated with routine western medicine therapy. After treatment for 36 days, the therapeutic effects were recorded and analyzed statistically. RESULTS: The total effective rate was 94.7% in the acupoint-injection group and 76.3% in the western medicine group with a significant difference between the two groups (P < 0.05); there was a significant difference between the two groups in eyeball moving rate and restoration of cateral rectus (P < 0.05). CONCLUSION: Chinese drug acupoint-injection therapy has a definite therapeutic effect on acquired abducent paralysis, which is better than that of routine western medicine.
    [Abstract] [Full Text] [Related] [New Search]